References
- 1
Barrett N R.
Chronic peptic ulcer of the oesophagus and “oesophagitis”.
Br J Surg.
1950;
38
175-182
- 2
McClave S A, Boyce jr. H W, Gottfried M R.
Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion.
Gastrointest Endosc.
1987;
33
413-416
- 3
Choi D W, Oh S N, Baek S J. et al .
Endoscopically observed lower esophageal capillary patterns.
Korean J Intern Med.
2002;
17
245-248
- 4
Vianna A, Hayes P C, Moscoso G. et al .
Normal venous circulation of the gastroesophageal junction. A route to understanding
varices.
Gastroenterology.
1987;
93
876-889
- 5
Paull A, Trier J S, Dalton M D. et al .
The histologic spectrum of Barrett's esophagus.
N Engl J Med.
1976;
295
476-480
- 6
Spechler S J, Goyal R K.
The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.
Gastroenterology.
1996;
110
614-621
- 7
Chandrasoma P.
Pathophysiology of Barrett's esophagus.
Semin Thorac Cardiovasc Surg.
1997;
9
270-278
- 8
Dresner S M, Griffin S M, Wayman J. et al .
Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia.
Br J Surg.
2003;
90
1120-1128
- 9
Takubo K, Aida J, Naomoto Y. et al .
Cardiac rather than intestinal-type background in endoscopic resection specimens of
minute Barrett adenocarcinoma.
Hum Pathol.
2008;
- 10
Playford R J.
New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management
of Barrett's oesophagus.
Gut.
2006;
55
442
- 11
Shaheen N J, Crosby M A, Bozymski E M, Sandler R S.
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?.
Gastroenterology.
2000;
119
333-338
- 12
Wang K K, Sampliner R E.
Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.
Am J Gastroenterol.
2008;
103
788-797
- 13
Eisen G M, Montgomery E A, Azumi N. et al .
Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trials.
Gastrointest Endosc.
1999;
50
814-818
- 14
Sharma P, Falk G W, Weston A P. et al .
Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
Clin Gastroenterol Hepatol.
2006;
4
566-572
- 15
Konda V J, Ross A S, Ferguson M K. et al .
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's
esophagus overestimated?.
Clin Gastroenterol Hepatol.
2008;
6
159-164
- 16
Montgomery E, Bronner M P, Goldblum J R. et al .
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.
Hum Pathol.
2001;
32
368-378
- 17
Alikhan M, Rex D, Khan A. et al .
Variable pathologic interpretation of columnar lined esophagus by general pathologists
in community practice.
Gastrointest Endosc.
1999;
50
23-26
- 18
Overholt B F, Lightdale C J, Wang K K. et al .
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in
Barrett's esophagus: international, partially blinded, randomized phase III trial.
Gastrointest Endosc.
2005;
62
488-498
- 19
Shaheen N J, Sharma P, Overholt B F. et al .
A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA)
for subjects with Barrett's esophagus (BE) containing dysplasia: interim results of
the AIM Dysplasia Trial.
Gastroenterology.
2008;
134
A37
- 20
Schoenfeld P, Cook D, Hamilton F. et al .
An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology
Steering Group.
Gastroenterology.
1998;
114
1318-1325
- 21
Spechler S J.
Dysplasia in Barrett's esophagus: limitations of current management strategies.
Am J Gastroenterol.
2005;
100
927-935
- 22
Ormsby A H, Petras R E, Henricks W H. et al .
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.
Gut.
2002;
51
671-676
- 23
Skacel M, Petras R E, Gramlich T L. et al .
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for
disease progression.
Am J Gastroenterol.
2000;
95
3383-3387
- 24
Attwood S E, Lewis C J, Caplin S. et al .
Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Clin Gastroenterol Hepatol.
2003;
1
258-263
- 25
Gurski R R, Peters J H, Hagen J A. et al .
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence
and predictive features.
J Am Coll Surg.
2003;
196
706-712
- 26
Bright T, Watson D I, Tam W. et al .
Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett
esophagus after antireflux surgery: late results.
Ann Surg.
2007;
246
1016-1020
- 27 Medical Dictionary for Regulatory Activities (MedDRA). http://www.meddramsso.com
N. J. ShaheenMD
University of North Carolina School of Medicine
CB#7080
Chapel Hill, NC 27599-7080
USA
Fax: 01-919-843-2508
eMail: nshaheen@med.unc.edu
